Clinical Trials Directory

Trials / Completed

CompletedNCT02914236

Treatment of Nasal Airway Obstruction Using the Aerin Medical Device

A Prospective, Multi-Center Non-Randomized Study to Evaluate Treatment of Nasal Airway Obstruction Using the Aerin Medical Device

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Aerin Medical · Industry
Sex
All
Age
22 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Evaluation of the Aerin Medical Device used for the treatment of nasal obstruction.

Detailed description

This is a non-significant risk, prospective, multi-center, non-randomized study to evaluate the safety and efficacy of the Aerin Medical device (Vivaer Stylus) when used to deliver radiofrequency (RF) energy to the nasal valve area to improve symptoms in those diagnosed with nasal airway obstruction.

Conditions

Interventions

TypeNameDescription
DEVICEVivaer StylusDelivery of low-power, temperature-controlled, radiofrequency energy to the tissues of the internal nasal valve area

Timeline

Start date
2016-09-27
Primary completion
2017-07-21
Completion
2017-08-18
First posted
2016-09-26
Last updated
2019-05-21
Results posted
2018-03-06

Locations

9 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02914236. Inclusion in this directory is not an endorsement.

Treatment of Nasal Airway Obstruction Using the Aerin Medical Device (NCT02914236) · Clinical Trials Directory